fda compounding semaglutide news october 2025 issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Compounders Sue FDA for Declaring

Labs managing multiple open vials simultaneously benefit from a simple log sheet or digital tracking system that records vial ID, puncture date, and discard date for each unit in use

Researchers wanted to determine whether the same genetic changes also affected GLP-1, a hormone released from the gut that helps control blood sugar after eating by stimulating insulin production, slowing stomach emptying, and reducing appetite

The ability depends on your microbiomesomething that shifts with age, diet, and health statusmaking supplementation the most reliable way to get it

This drug would be indicated for the chronic management of obesity

This type of product may be less aligned with your needs if you require clinically validated weight management outcomes comparable to prescription medications, prefer full-disclosure CFU counts per individual strain, or expect rapid changes within the first week of use

James, C